Ì첩ÈüʹÙÍø

Will This Chinese Biotech Revolutionize Cancer Treatment?

Akeso, from China, unveiled to the world of biotech Ivonescimab—an advanced lung carcinoma model that outperformed Merck’s Keytruda in clinical trials. The big implication here: China’s...